Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/55503
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGutiérrez-Gutiérrez, G
dc.contributor.authorRosado-Bartolomé, A
dc.date.accessioned2022-10-04T07:15:49Z-
dc.date.available2022-10-04T07:15:49Z-
dc.date.issued2020
dc.identifier.citationRev Neurol.2020;(70)7:269
dc.identifier.urihttps://hdl.handle.net/20.500.12530/55503-
dc.language.isoes
dc.subject.meshDrug Repositioning
dc.subject.meshHumans
dc.subject.meshMyotonic Dystrophy
dc.title[Therapeutic drug repositioning and Steinert's disease].
dc.title.alternativeReposicionamiento terapéutico y enfermedad de Steinert.
dc.typeArtículo
dc.identifier.pubmedID32182375
dc.format.volume70
dc.format.page269
dc.identifier.e-issn1576-6578
dc.identifier.journalRevista de neurologia
dc.identifier.journalabbreviationRev Neurol
dc.identifier.doi10.33588/rn.7007.2020030
dc.format.number7
dc.pubmedtypeLetter
Appears in Collections:Fundaciones e Institutos de Investigación > FIIB H. U. Infanta Sofía y H. U. Henares > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.